How Valid Are Imaging Biomarkers for ADHD?

PostedOctober 6, 2025

UpdatedOctober 6, 2025

ByMy Patient Advice

Author: Phoebe Carter, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

The validity of ADHD imaging biomarkers is an evolving area of research, with scientists working to determine whether brain scans can reliably identify neurobiological markers of the condition. While imaging techniques like MRI and fMRI have revealed some consistent brain differences in people with ADHD, the reliability and clinical utility of these markers remain limited in everyday practice.

Common findings include structural or functional changes in regions like the prefrontal cortex, basal ganglia, and cerebellum, areas involved in attention, impulse control, and motor regulation. These ADHD imaging biomarkers suggest underlying brain differences but are not yet specific or accurate enough to serve as formal diagnostic tools. At this stage, they are better viewed as supplementary information to support, rather than replace, comprehensive clinical assessment.

Common Biomarkers and Their Relevance

While brain imaging markers provide valuable scientific insight, they are not yet used in routine clinical settings. Here’s what some of the most commonly discussed biomarkers suggest and how treatment may help.

Prefrontal Cortex Underactivity

This marker is associated with poor attention, weak planning skills, and impulsivity. While it appears frequently in people with ADHD, it’s not exclusive to the condition. Stimulant medication can help normalise activity in this area, and CBT is effective for improving executive function.

Basal Ganglia Irregularities

Often linked to hyperactivity and motor control difficulties, this marker appears in both ADHD and other neurodevelopmental conditions. While not diagnostic, these irregularities can guide treatment decisions. Medication and behavioural therapy remain key interventions.

Visit providers like ADHD Certify for personal consultations to better understand how brain imaging can inform ADHD treatment.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to ADHD brain imaging findings.

Phoebe Carter, MSc

Author

Phoebe Carter is a clinical psychologist with a Master’s in Clinical Psychology and a Bachelor’s in Applied Psychology. She has experience working with both children and adults, conducting psychological assessments, developing individualized treatment plans, and delivering evidence-based therapies. Phoebe specialises in neurodevelopmental conditions such as autism spectrum disorder (ASD), ADHD, and learning disabilities, as well as mood, anxiety, psychotic, and personality disorders. She is skilled in CBT, behaviour modification, ABA, and motivational interviewing, and is dedicated to providing compassionate, evidence-based mental health care to individuals of all ages.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.